Open access · CC-BY
via OpenAlex
Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages
Guozhu Ye, Guoyou Chen, Han Gao, Yi Lin, Xu Liao, Han Zhang, Xinyu Liu, Yulang Chi, Qiansheng Huang, Huimin Zhu, Yuhua Fan, Sijun Dong
Journal of Cellular and Molecular Medicine · 2019 · ▲ 53 citations
Abstract
Disordered intestinal metabolism is highly correlated with atherosclerotic diseases. Resveratrol protects against atherosclerotic diseases. Accordingly, this study aims to discover novel intestinal proatherosclerotic metabolites and potential therapeutic targets related to the anti-atherosclerotic effects of resveratrol. An untargeted metabolomics approach was employed to discover novel intestinal metabolic disturbances during atherosclerosis and resveratrol intervention. We found that multiple intestinal metabolic pathways were significantly disturbed during atherosclerosis and responsive to resveratrol intervention. Notably, resveratrol abolished intestinal fatty acid and monoglyceride accumulation in atherosclerotic mice. Meanwhile, oleate accumulation was one of the most prominent alterations in intestinal metabolism. Moreover, resveratrol attenuated oleate-triggered accumulation of total cholesterol, esterified cholesterol and neutral lipids in mouse RAW 264.7 macrophages by activating ABC transporter A1/G1-mediated cholesterol efflux through PPAR (peroxisome proliferator-activated receptor) α/γ activation. Furthermore, we confirmed that PPARα and PPARγ activation by WY14643 and pioglitazone, respectively, alleviated oleate-induced accumulation of total cholesterol, esterified cholesterol and neutral lipids by accelerating ABC transporter A1/G1-mediated cholesterol efflux. This study provides the first evidence that resveratrol abolishes intestinal fatty acid and monoglyceride accumulation in atherosclerotic mice, and that resveratrol suppresses oleate-induced accumulation of total cholesterol, esterified cholesterol and neutral lipids in macrophages by activating PPARα/γ signalling.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jcmm.14323
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Ye, G., Chen, G., Gao, H., Lin, Y., Liao, X., Zhang, H., Liu, X., Chi, Y., Huang, Q., Zhu, H., Fan, Y., & Dong, S. (2019). Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages. <em>Journal of Cellular and Molecular Medicine</em>. https://doi.org/10.1111/jcmm.14323
Vancouver
Ye G, Chen G, Gao H, Lin Y, Liao X, Zhang H, et al. Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages. Journal of Cellular and Molecular Medicine. 2019. doi:10.1111/jcmm.14323.
BibTeX
@article{guozhu2019Resver,
title = {Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages},
author = {Guozhu Ye and Guoyou Chen and Han Gao and Yi Lin and Xu Liao and Han Zhang and Xinyu Liu and Yulang Chi and Qiansheng Huang and Huimin Zhu and Yuhua Fan and Sijun Dong},
journal = {Journal of Cellular and Molecular Medicine},
year = {2019},
doi = {10.1111/jcmm.14323},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neuroscience 2014
Open access · OA
Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults
Drug Metabolism and Pharmacokinetics 2010
Preprint · OA
In vitro Intestinal Absorption and First-pass Intestinal and Hepatic Metabolism of Cycloastragenol, a Potent Small Molecule Telomerase Activator
PLoS Pathogens 2020
Open access · CC-BY
CFTR dysregulation drives active selection of the gut microbiome
Journal of Nutrition and Metabolism 2011
Open access · CC-BY
Distinct Effects of Calorie Restriction and Resveratrol on Diet-Induced Obesity and Fatty Liver Formation
PLoS ONE 2013
Open access · CC-BY
Resveratrol Protects Mouse Oocytes from Methylglyoxal-Induced Oxidative Damage
Journal of Pharmacology and Experimental Therapeutics 2009
Open access · OA